← Leaderboards
Vadim Jucaud
Terasaki Institute For Biomedical Innovation
$1,665,283
Attributed
$1,665,283
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $852.8K · FY2024–25$1M$750K$500K$250K$0
'24
'25
Funding mix
By agency
NIH$1,665,283 · 2
By mechanism
R01$1,222,258 · 1
R21$443,025 · 1
Top collaborators
No co-investigators on record.
Most similar at Terasaki Institute For Biomedical Innovation
Same institution · by research overlap
- Xiling Shen$12,361,494
Others in their field
Other Rising Stars on “Endothelium”
- John Paderi John Paderi John Paderi · Ihp Therapeutics, Inc.$6,183,017
- Andrew Chris Yang · University Of California, San Francisco$4,324,660
- Charles Dimmler III · Ceramedix Holding, Llc$4,223,612
- Sarah Elizabeth Lutz · University Of Illinois At Chicago$3,911,564
- Bozena Korczak · Vascular Vision Pharmaceuticals Company$3,058,782
- Galina Vid · Ceramedix Holding, Llc$3,007,043
Research focus
EndotheliumFibroblastsDisease ModelEndothelial CellsEnd-Stage Organ FailureEngineeringAllograftingCytokineDonor-Specific AntibodyDrug ScreeningAllograft ToleranceBindingBiological MarkersAllogenicAntibodiesBloodAntibody-Mediated RejectionCost EffectiveCell LineAllograft RejectionAccelerationDrug DevelopmentClinicFunctional Disorder
Grant awards (4)
Vascularized liver-heart on-a-chip modeling antibody-mediated rejection and tolerance of allografts$611,129
R01 · FY2025 · AI · contact PI
Vascularized liver on-a-chip modeling cellular and humoral rejection of allografts$201,375
R21 · FY2025 · EB · contact PI
Vascularized liver-heart on-a-chip modeling antibody-mediated rejection and tolerance of allografts$611,129
R01 · FY2024 · AI · contact PI
Vascularized liver on-a-chip modeling cellular and humoral rejection of allografts$241,650
R21 · FY2024 · EB · contact PI